Search for: "Bayer and Bayer"
Results 161 - 180
of 3,409
Sort by Relevance
|
Sort by Date
28 Dec 2021, 1:48 am
(T 966/18) (14 July 2021)Bayer v Teva: Drug fo [read post]
14 Dec 2021, 10:16 am
The odds of Bayer winning this appeal are very small, but yesterday the Supreme Court gave Bayer a small ray of hope by asking the Biden administration to weigh in on whether to hear Bayer’s appeal. [read post]
14 Dec 2021, 6:57 am
Here’s the Tuesday morning read: Supreme Court Allows Vaccine Mandate for New York Health Care Workers (Adam Liptak, The New York Times) Bayer Bid to End Roundup Suits Draws U.S. [read post]
10 Dec 2021, 12:19 pm
PatentsGuestKat Rose Hughes analysed a recent decision of the English High Court regarding the clinical formulation of Bayer's cancer drug, sorafenib. [read post]
1 Dec 2021, 11:51 am
Roundup In May, the MDL judge formally rejected Bayer’s controversial global settlement that would have stayed future Roundup lawsuits. [read post]
30 Nov 2021, 2:19 am
On 25 November 2021, the European Commission has published its comprehensive legislative proposal package to reinforce democracy and protect the integrity of elections. [read post]
28 Nov 2021, 6:58 am
It remains to be seen whether Bayer will seek appeal to the Court of Appeal in the UK. [read post]
19 Nov 2021, 7:47 am
Written by Sarah Bayer Edited by Gary J. [read post]
18 Nov 2021, 6:59 am
After spending the last few years under siege from Roundup lawsuits, Bayer AG announced in a recent quarterly earnings report that it has tentatively settled 98,000 Roundup lawsuits. [read post]
11 Nov 2021, 11:06 am
3 Nov 2021, 1:38 pm
The Bayer lawsuit alleges wrongdoing by the company’s supervisory board in connection with the company’s ill-fated merger with Monsanto. [read post]
3 Nov 2021, 1:38 pm
The Bayer lawsuit alleges wrongdoing by the company’s supervisory board in connection with the company’s ill-fated merger with Monsanto. [read post]
29 Oct 2021, 11:15 am
This week in Other Barks & Bites: the Federal Circuit issues a partial remand asking the Trademark Trial and Appeal Board (TTAB) to analyze the distinctiveness of the “BROOKLYN BREW SHOP” trademark; the Copyright Royalty Board finalizes its ratemaking determination for statutory licenses on digital performances of sound recordings; China’s IP administration issues draft regulations that would allow foreign patent agencies to open representative offices in China; a joint… [read post]
29 Oct 2021, 11:15 am
This week in Other Barks & Bites: the Federal Circuit issues a partial remand asking the Trademark Trial and Appeal Board (TTAB) to analyze the distinctiveness of the “BROOKLYN BREW SHOP” trademark; the Copyright Royalty Board finalizes its ratemaking determination for statutory licenses on digital performances of sound recordings; China’s IP administration issues draft regulations that would allow foreign patent agencies to open representative offices in China; a joint… [read post]
27 Oct 2021, 9:19 am
After 3 bellwether test trials (with disastrous results for Bayer) and a rejected global settlement proposal, the Roundup MDL is currently in holding mode as Bayer has been settling large blocks pending cases. [read post]
27 Oct 2021, 5:15 am
Bayer Consumer Care AG, No. 21-195 (impact of foreign use on trademark rights in the US); Australian Leather Pty. [read post]
21 Oct 2021, 6:54 am
That has justices worried (Russ Feingold, The Guardian) The Supreme Court’s Chance to Defend Religious Liberty (Andrea Picciotti-Bayer, National Review) Supreme Court Term Limits Are Not Going to Cut It (Jay Willis, Balls and Strikes) The post The morning read for Thursday, Oct. 21 appeared first on SCOTUSblog. [read post]
19 Oct 2021, 8:05 am
On Friday, November 5, 2021, Fernando Navarro and Disputing blog’s own Karl Bayer will be moderating the International Academy of Mediators‘ (IAM) “Mediation 2021: Where Do We Go from Here? [read post]
11 Oct 2021, 8:16 am
While you may have noticed how expensive your recent trips to the supermarket have become, have you thought about why? [read post]
7 Oct 2021, 1:59 am
Monsanto - currently taken over by Bayer - might have learned the lesson not to rely on the filière system alone to safeguard its technology but also on IP. [read post]
